Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Common Stock | Award | $62.5K | +30.8K | +19.25% | $2.03 | 191K | Feb 22, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Restricted Stock Units | Award | $0 | +61.6K | $0.00 | 61.6K | Feb 22, 2022 | Common Stock | 61.6K | Direct | F2, F3 | ||
transaction | PGEN | Option to Purchase Common Stock (Right to Buy) | Award | $0 | +83.2K | $0.00 | 83.2K | Feb 22, 2022 | Common Stock | 83.2K | $2.03 | Direct |
Id | Content |
---|---|
F1 | The shares were issued to the reporting person in lieu of an annual retainer of $62,500. |
F2 | Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. |
F3 | The RSUs vest in full on February 22, 2023. |